Search results
Results from the WOW.Com Content Network
9518 23886 Ensembl ENSG00000130513 ENSMUSG00000038508 UniProt Q99988 Q9Z0J7 RefSeq (mRNA) NM_004864 NM_011819 NM_001330687 RefSeq (protein) NP_004855 NP_001317616 NP_035949 Location (UCSC) Chr 19: 18.37 – 18.39 Mb Chr 8: 71.08 – 71.09 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Growth/differentiation factor 15 is a protein that in humans is encoded by the GDF15 gene. GDF15 ...
2660 17700 Ensembl ENSG00000138379 ENSMUSG00000026100 UniProt O14793 O08689 RefSeq (mRNA) NM_005259 NM_010834 RefSeq (protein) NP_005250 NP_034964 Location (UCSC) Chr 2: 190.06 – 190.06 Mb Chr 1: 53.1 – 53.11 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse In humans, the MSTN gene is located on the long (q) arm of chromosome 2 at position 32.2. Myostatin (also known as growth ...
Several members of this subfamily have been described, and named GDF1 through GDF15. GDF1 is expressed chiefly in the nervous system and functions in left-right patterning and mesoderm induction during embryonic development.
Ponsegromab (PF-06946860) is a monoclonal antibody that works as a GDF-15 inhibitor. It is developed by Pfizer for cancer cachexia. [1] [2] [3] [4] [5]In September ...
GDF2 contains an N-terminal TGF-beta-like pro-peptide (prodomain) (residues 56–257) and a C-terminal transforming growth factor beta superfamily domain (325–428). [6] GDF2 (BMP9) is secreted as a pro-complex consisting of the BMP9 growth factor dimer non-covalently bound to two BMP9 prodomain molecules in an open-armed conformation.
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Alzheimer's disease is the most common form of dementia, affecting more than three million Americans ...
GDF knock-out mice display skeletal defects as a result of patterning problems with anterior-posterior positioning. [16] This cytokine also inhibits the proliferation of olfactory receptor neural progenitors to regulate the number of neurons in the olfactory epithelium , [ 17 ] and controls the competence of progenitor cells to regulate numbers ...
From January 2008 to December 2012, if you bought shares in companies when Lloyd H. Dean joined the board, and sold them when he left, you would have a 12.1 percent return on your investment, compared to a -2.8 percent return from the S&P 500.